Journal of Controlled Release

Papers
(The H4-Index of Journal of Controlled Release is 81. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Self-assembled hyaluronic acid nanoparticles for the topical treatment of inflammatory skin diseases: Beyond drug carriers561
Protein and peptide-based renal targeted drug delivery systems457
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment353
Intradermal delivery of the antiretroviral drugs cabotegravir and rilpivirine by dissolving microarray patches: Investigation of lymphatic uptake332
Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer265
Polymyxin B-targeted liposomal photosensitizer cures MDR A. baumannii burn infections and accelerates wound healing via M1/M2 macrophage polarization242
Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment199
Enhancing gene transfection of poly(β-amino ester)s through modulation of amphiphilicity and chain sequence197
Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles196
Electromechanical convective drug delivery devices for overcoming diffusion barriers196
Recent advances in drug delivery and targeting for the treatment of pancreatic cancer196
Development of anti-PEG IgG/IgM/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy195
Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy192
Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis185
Efficient gene delivery by multifunctional star poly (β-amino ester)s into difficult-to-transfect macrophages for M1 polarization184
Differentiated mesenchymal stem cells-derived exosomes immobilized in decellularized sciatic nerve hydrogels for peripheral nerve repair180
Mesoporous zinc oxide-based drug delivery system offers an antifungal and immunoregulatory strategy for treating keratitis178
STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia171
Inside Back Cover165
Smart exosomes enhance PDAC targeted therapy161
Glucose-responsive insulin microneedle patches for long-acting delivery and release visualization160
Bacteria-based drug delivery for treating non-oncological diseases160
ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment159
Outside Back Cover153
A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes152
Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy152
An antibacterial, multifunctional nanogel for efficient treatment of neutrophilic asthma145
Recent nanoengineered diagnostic and therapeutic advancements in management of Sepsis144
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions142
Inhaled deep eutectic solvent based-nanoemulsion of pirfenidone in idiopathic pulmonary fibrosis140
Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?138
Metal-organic frameworks: A promising option for the diagnosis and treatment of Alzheimer's disease138
Evolution of drug delivery systems: From 1950 to 2020 and beyond133
An oxidative stress-responsive electrospun polyester membrane capable of releasing anti-bacterial and anti-inflammatory agents for postoperative anti-adhesion128
PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting125
Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation124
Cavitation-assisted sonothrombolysis by asymmetrical nanostars for accelerated thrombolysis123
Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability122
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors119
Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration115
Cryogel microcarriers for sustained local delivery of growth factors to the brain115
Spatiotemporally-controlled hydrophobic drug delivery via photosensitizer-driven assembly-disassembly for enhanced triple-negative breast cancer treatment114
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome114
Transform nanomedicine with breakthrough thinking?109
Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis109
Microparticle fabricated from a series of symmetrical lipids based on dihydroxyacetone form textured architectures109
Nanoparticle platform comprising lipid-tailed pH-sensitive carbon dots with minimal drug loss108
Outside Back Cover108
A therapeutic DC vaccine with maintained immunological activity exhibits robust anti-tumor efficacy107
Spatially regulated activation of membrane fusogenic peptides with chaperone-like ionic copolymers106
Outside Front Cover106
Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats105
Content list including Graphcal Abstracts103
Prediction of drug capturing by lipid emulsions in vivo for the treatment of a drug overdose103
Outside Back Cover102
Outside Back Cover101
Inside Back Cover100
Targeted delivery of CD163+ macrophage-derived small extracellular vesicles via RGD peptides promote vascular regeneration and stabilization after spinal cord injury99
Letter to the editor regarding “Translation of focused ultrasound for blood-brain barrier opening in glioma”97
Surgical management of peritoneal metastasis: Opportunities for pharmaceutical research96
Mechanisms of cellular retention of melanin bound drugs: Experiments and computational modeling96
Protein corona-driven nanovaccines improve antigen intracellular release and immunotherapy efficacy96
Employing single valency polyphenol to prepare metal-phenolic network antitumor reagents through FeOOH assistance94
Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsy93
A tribute to my biosimilar91
Contents list including Graphcal Abstracts89
Editorial Board89
Controlled delivery systems are the cornerstone of advanced therapies and vaccines: An Asian perspective88
Inside Front Cover88
An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction87
Editorial Board87
Antigen-specific T cell activation through targeted delivery of in-situ generated antigen and calcium ionophore to enhance antitumor immunotherapy86
Dynamic immuno-nanomedicines in oncology85
Photochemical internalization (PCI)-mediated activation of CD8 T cells involves antigen uptake and CCR7-mediated transport by migratory dendritic cells to draining lymph nodes85
Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer84
Small EV-based delivery of CpG ODNs for melanoma postsurgical immunotherapy84
Inside Front Cover84
Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery83
Inside Front Cover83
A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT381
Outside Back Cover81
0.13501000404358